• 134 Investors
  • Mitochondria in Longevity. Switzerland Overview
1. 4SC 1997
2. 6 Dimensions Capital 0
3. Abbott 1944
4. Abingworth 1973
5. Adams Street Partners
6. Aisling Capital
7. Altitude Life Science Ventures
8. Alzheimer's Association
9. AME Cloud Ventures 2012
10. Amzak Health Investors 2015
11. Andera Partners 1953
12. Andreessen Horowitz
13. Apollo Health Ventures
14. ARCH Venture Partners
15. Arix Bioscience
16. Armistice Capital LLC 2012
17. ArrowMark Partners
18. ARUP Laboratories 1983
19. Astellas Pharma 2005
20. Atlantis Investment Management
21. Atlas Venture
22. aws Gründerfonds (aws Founders Fund) 2013
23. Axil Capital 2017
24. Baillie Gifford 0
25. Bayern Kapital
26. Bezos Expeditions
27. BiomedPartners
28. Blackstone Life Sciences
29. Blue Ivy Ventures 2016
30. Bpifrance 0
31. Brace Pharma
32. Broadview Ventures 0
33. Caffeinated Capital
34. Cahc co., Ltd.
35. Castor Ventures 2016
36. Chiesi Ventures
37. Crédit Agricole
38. Cycad Group
39. Dementia Discovery Fund
40. DPE Deutsche Private Equity 2007
41. Eclosion SA 2001
42. EcoR1 Capital
43. Edmond de Rothschild Private Equity 1953
44. EFung Capital 1996
45. Felicis Ventures 10
46. Fidelity Management and Research Company 1946
47. Fondation d'Aide aux Entreprises 1
48. Founders Fund 0
49. Genentech 1976
50. Gimv 25
51. Grampian Biopartners 2008
52. Highbridge Capital Management 1992
53. Illumina 1998
54. Imperial Innovations 1986
55. Index Ventures 1996
56. Invus 1985
57. IP Group Plc 2001
58. Jennison Associates 1969
59. Johnson & Johnson Development Corporation 1979
60. Khosla Ventures
61. Kingdon Capital 0
62. Kreos Capital 1998
63. Life Science Angels 2004
64. Longitude Capital
65. Longwood Fund 2010
66. Lundbeckfonden Ventures
67. Mayfield Fund
68. Mayo Clinic
69. Morningside Venture Investments
70. MP Healthcare Venture Management 2006
71. MPM Capital
72. National Institute of Neurological Disorders and Stroke 0
73. National Institutes of Health 0
74. National Multiple Sclerosis Society (NMSS) 1946
75. Neomed Management 1997
76. New Enterprise Associates
77. New Wave Ventures
78. NGN Capital 2003
79. Nippon Venture Capital
80. North Texas Angel Network
81. Novartis Venture Fund 1996
82. Novo Holdings
83. Nyenburgh Investment Partners 2013
84. Omnes Capital
85. OrbiMed
86. Oxford Bioscience Partners 1992
87. Oxford Finance LLC 2002
88. Pappas Capital 1
89. Partner Fund Management 2004
90. Pear VC 2013
91. Perceptive Advisors
92. Pfizer Venture Investments
93. Polaris Partners
94. PTC Therapeutics 1998
95. Reata Pharmaceuticals 2002
96. Redpoint
97. Refactor Capital 2016
98. Remiges Ventures
99. RiverVest 2000
100. RMB Funds 2005
101. RM Global Partners
102. Roche Venture Fund
103. Rock Springs Capital
104. Sagamore Investments 2002
105. Sanofi Ventures
106. Schroder Adveq 1997
107. SDL Ventures 2003
108. Shanda Group 1999
109. Silicon Valley Bank 0
110. Societe Generale Asset Management
111. Sofinnova Partners
112. SOSV 0
113. Sphera Funds Management 2004
114. SR One
115. State Development & Investment Corporation (SDIC) 1995
116. Stealth BioTherapeutics 2007
117. Takeda 1781
118. The Longevity Fund 2011
119. Three Lakes Partners
120. TRICAPITAL 2004
121. TVM Capital Life Science 1983
122. UNITY Biotechnology 2009
123. University of California 1868
124. University of Southern California 1880
125. University of Washington 1861
126. Venrock
127. Vertex Ventures HC 2014
128. Vesalius Biocapital Partners
129. VI Partners
130. Vulcan Capital 2019
131. Wellington Partners
132. Woodford Investment Management
133. WuXi AppTec
134. Yale University 1701

«Mitochondria in Longevity. Switzerland Overview»

  • — investor and funding support bodies
  • — hubs and other organisation types

Industries

AI
AI R&D Pharma (DPI)
Artificial Intelligence, Pharmaceutical, Robotics, Venture Capital
Asset Management, Financial Services, Risk Management
Biotechnology
Communities, Education, Systemic, Training, Universities
Content and Publishing, Financial Services, Lending and Investments, Media and Entertainment, Video
Education, Medical, Non Profit
Energetic Process
FemTech
FinTech, Financial Services, Government
Finance
Financial Services
Financial Services, Health Care, Lending and Investments
Financial Services, Health Care, Venture Capital
Financial Services, Impact Investing, Venture Capital
Financial Services, Intellectual Property
Global Health Challenges
Healthcare
Investment Funds
Investor
Longevity
Longevity Industry 2022
Longevity and HealthTech Governance Organisations
Venture Capital
mHealth

test_custom_domain_2
© 2025